Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Stephanie Rachel Jost, Ph.D.

TitleInstructor in Medicine
InstitutionMassachusetts General Hospital
DepartmentMedicine
AddressRagon Institute of MGH, MIT and Harvard
# 954
400 Technology Square
Cambridge MA 02139
Phone857/268-7176

 Biography 
 awards and honors
1996 - Givaudan-Roure award in physics and chemistry
2003 - Arditi award
2008 - 2009Prospective Researcher Fellowship, Swiss National Science Foundation
2009 - 2010Postdoctoral fellowship award from the MGH ECOR Fund for Medical Discovery

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Jost S, Moreno-Nieves UY, Garcia-Beltran WF, Rands K, Reardon J, Toth I, Piechocka-Trocha A, Altfeld M, Addo MM. Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infection. Retrovirology. 2013; 10(1):74.
    View in: PubMed
  2. Jost S, Altfeld M. Control of human viral infections by natural killer cells. Annu Rev Immunol. 2013 Mar 21; 31:163-94.
    View in: PubMed
  3. Jost S, Altfeld M, Chang JJ. Harnessing innate and adaptive immunity for viral vaccine design. Expert Rev Vaccines. 2012 Jul; 11(7):775-7.
    View in: PubMed
  4. Jost S, Altfeld M. Evasion from NK cell-mediated immune responses by HIV-1. Microbes Infect. 2012 Sep; 14(11):904-15.
    View in: PubMed
  5. Jost S, Quillay H, Reardon J, Peterson E, Simmons RP, Parry BA, Bryant NN, Binder WD, Altfeld M. Changes in cytokine levels and NK cell activation associated with influenza. PLoS One. 2011; 6(9):e25060.
    View in: PubMed
  6. Jost S, Reardon J, Peterson E, Poole D, Bosch R, Alter G, Altfeld M. Expansion of 2B4+ natural killer (NK) cells and decrease in NKp46+ NK cells in response to influenza. Immunology. 2011 Apr; 132(4):516-26.
    View in: PubMed
  7. Ackerman ME, Moldt B, Wyatt RT, Dugast AS, McAndrew E, Tsoukas S, Jost S, Berger CT, Sciaranghella G, Liu Q, Irvine DJ, Burton DR, Alter G. A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples. J Immunol Methods. 2011 Mar 7; 366(1-2):8-19.
    View in: PubMed
  8. Alter G*, Jost S*, Rihn S, Reyor LL, Nolan BE, Ghebremichael M, Bosch R, Altfeld M, Lauer GM. *co-first authors. Reduced frequencies of NKp30+NKp46+, CD161+ and NKG2D+ NK cells in acute HCV infection may predict viral clearance. J Hepatol. . 2010.
  9. Nolting A, Dugast AS, Rihn S, Luteijn R, Carrington MF, Kane K, Jost S, Toth I, Nagami E, Faetkenheuer G, Hartmann P, Altfeld M, Alter G. MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction. Virology. 2010 Oct 10; 406(1):12-20.
    View in: PubMed
  10. Turelli P, Liagre-Quazzola A, Mangeat B, Verp S, Jost S, Trono D. APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice. J Virol. 2008 Jul; 82(13):6585-90.
    View in: PubMed
  11. Jost S, Turelli P, Mangeat B, Protzer U, Trono D. Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons. J Virol. 2007 Oct; 81(19):10588-96.
    View in: PubMed
  12. Yerly S, Jost S, Monnat M, Telenti A, Cavassini M, Chave JP, Kaiser L, Burgisser P, Perrin L. HIV-1 co/super-infection in intravenous drug users. AIDS. 2004 Jul 2; 18(10):1413-21.
    View in: PubMed
  13. Yerly S, Jost S, Telenti A, Flepp M, Kaiser L, Chave JP, Vernazza P, Battegay M, Furrer H, Chanzy B, Burgisser P, Rickenbach M, Gebhardt M, Bernard MC, Perneger T, Hirschel B, Perrin L. Infrequent transmission of HIV-1 drug-resistant variants. Antivir Ther. 2004 Jun; 9(3):375-84.
    View in: PubMed
  14. Turelli P*, Jost S*, Mangeat B, Trono D. *co-first authors. Response to Comment on "Inhibition of Hepatitis B Virus Replication by APOBEC3G". Science. 305(5689):1403b . 2004.
  15. Turelli P*, Mangeat B*, Jost S*, Vianin S, Trono D. *co-first authors. Inhibition of hepatitis B virus replication by APOBEC3G. Science. Mar 19; 303(5665):1829. 2004.
  16. Jost S, Bernard MC, Kaiser L, Yerly S, Hirschel B, Samri A, Autran B, Goh LE, Perrin L. A patient with HIV-1 superinfection. N Engl J Med. 2002 Sep 5; 347(10):731-6.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Jost's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_